We've found
15,024
archived clinical trials in
Infectious Disease
We've found
15,024
archived clinical trials in
Infectious Disease
MeFirst: A Tailored Intervention to HPV Vaccine Decision Making
Updated: 7/21/2015
MeFirst: A Tailored Intervention to HPV Vaccine Decision Making
Status: Enrolling
Updated: 7/21/2015
MeFirst: A Tailored Intervention to HPV Vaccine Decision Making
Updated: 7/21/2015
MeFirst: A Tailored Intervention to HPV Vaccine Decision Making
Status: Enrolling
Updated: 7/21/2015
Click here to add this to my saved trials
Efficacy of Combination Therapies for Gonorrhea Treatment
Updated: 7/23/2015
Randomized Clinical Trial Evaluating the Efficacy of Gentamicin/Azithromycin and Gemifloxacin/Azithromycin Combination Therapies as an Alternative Regimen for Uncomplicated Urogenital Gonorrhea
Status: Enrolling
Updated: 7/23/2015
Efficacy of Combination Therapies for Gonorrhea Treatment
Updated: 7/23/2015
Randomized Clinical Trial Evaluating the Efficacy of Gentamicin/Azithromycin and Gemifloxacin/Azithromycin Combination Therapies as an Alternative Regimen for Uncomplicated Urogenital Gonorrhea
Status: Enrolling
Updated: 7/23/2015
Click here to add this to my saved trials
Efficacy of Combination Therapies for Gonorrhea Treatment
Updated: 7/23/2015
Randomized Clinical Trial Evaluating the Efficacy of Gentamicin/Azithromycin and Gemifloxacin/Azithromycin Combination Therapies as an Alternative Regimen for Uncomplicated Urogenital Gonorrhea
Status: Enrolling
Updated: 7/23/2015
Efficacy of Combination Therapies for Gonorrhea Treatment
Updated: 7/23/2015
Randomized Clinical Trial Evaluating the Efficacy of Gentamicin/Azithromycin and Gemifloxacin/Azithromycin Combination Therapies as an Alternative Regimen for Uncomplicated Urogenital Gonorrhea
Status: Enrolling
Updated: 7/23/2015
Click here to add this to my saved trials
Efficacy of Combination Therapies for Gonorrhea Treatment
Updated: 7/23/2015
Randomized Clinical Trial Evaluating the Efficacy of Gentamicin/Azithromycin and Gemifloxacin/Azithromycin Combination Therapies as an Alternative Regimen for Uncomplicated Urogenital Gonorrhea
Status: Enrolling
Updated: 7/23/2015
Efficacy of Combination Therapies for Gonorrhea Treatment
Updated: 7/23/2015
Randomized Clinical Trial Evaluating the Efficacy of Gentamicin/Azithromycin and Gemifloxacin/Azithromycin Combination Therapies as an Alternative Regimen for Uncomplicated Urogenital Gonorrhea
Status: Enrolling
Updated: 7/23/2015
Click here to add this to my saved trials
Efficacy of Combination Therapies for Gonorrhea Treatment
Updated: 7/23/2015
Randomized Clinical Trial Evaluating the Efficacy of Gentamicin/Azithromycin and Gemifloxacin/Azithromycin Combination Therapies as an Alternative Regimen for Uncomplicated Urogenital Gonorrhea
Status: Enrolling
Updated: 7/23/2015
Efficacy of Combination Therapies for Gonorrhea Treatment
Updated: 7/23/2015
Randomized Clinical Trial Evaluating the Efficacy of Gentamicin/Azithromycin and Gemifloxacin/Azithromycin Combination Therapies as an Alternative Regimen for Uncomplicated Urogenital Gonorrhea
Status: Enrolling
Updated: 7/23/2015
Click here to add this to my saved trials
Efficacy of Combination Therapies for Gonorrhea Treatment
Updated: 7/23/2015
Randomized Clinical Trial Evaluating the Efficacy of Gentamicin/Azithromycin and Gemifloxacin/Azithromycin Combination Therapies as an Alternative Regimen for Uncomplicated Urogenital Gonorrhea
Status: Enrolling
Updated: 7/23/2015
Efficacy of Combination Therapies for Gonorrhea Treatment
Updated: 7/23/2015
Randomized Clinical Trial Evaluating the Efficacy of Gentamicin/Azithromycin and Gemifloxacin/Azithromycin Combination Therapies as an Alternative Regimen for Uncomplicated Urogenital Gonorrhea
Status: Enrolling
Updated: 7/23/2015
Click here to add this to my saved trials
Evaluation of Accuracy and Ease of Use of the FilmArray™ Respiratory Panel (RP EZ) in a CLIA-Waived Clinical Setting
Updated: 7/23/2015
Evaluation of Accuracy and Ease of Use of the FilmArray™ Respiratory Panel (RP EZ) in a CLIA-Waived Clinical Setting
Status: Enrolling
Updated: 7/23/2015
Evaluation of Accuracy and Ease of Use of the FilmArray™ Respiratory Panel (RP EZ) in a CLIA-Waived Clinical Setting
Updated: 7/23/2015
Evaluation of Accuracy and Ease of Use of the FilmArray™ Respiratory Panel (RP EZ) in a CLIA-Waived Clinical Setting
Status: Enrolling
Updated: 7/23/2015
Click here to add this to my saved trials
Evaluation of Accuracy and Ease of Use of the FilmArray™ Respiratory Panel (RP EZ) in a CLIA-Waived Clinical Setting
Updated: 7/23/2015
Evaluation of Accuracy and Ease of Use of the FilmArray™ Respiratory Panel (RP EZ) in a CLIA-Waived Clinical Setting
Status: Enrolling
Updated: 7/23/2015
Evaluation of Accuracy and Ease of Use of the FilmArray™ Respiratory Panel (RP EZ) in a CLIA-Waived Clinical Setting
Updated: 7/23/2015
Evaluation of Accuracy and Ease of Use of the FilmArray™ Respiratory Panel (RP EZ) in a CLIA-Waived Clinical Setting
Status: Enrolling
Updated: 7/23/2015
Click here to add this to my saved trials
Evaluation of Accuracy and Ease of Use of the FilmArray™ Respiratory Panel (RP EZ) in a CLIA-Waived Clinical Setting
Updated: 7/23/2015
Evaluation of Accuracy and Ease of Use of the FilmArray™ Respiratory Panel (RP EZ) in a CLIA-Waived Clinical Setting
Status: Enrolling
Updated: 7/23/2015
Evaluation of Accuracy and Ease of Use of the FilmArray™ Respiratory Panel (RP EZ) in a CLIA-Waived Clinical Setting
Updated: 7/23/2015
Evaluation of Accuracy and Ease of Use of the FilmArray™ Respiratory Panel (RP EZ) in a CLIA-Waived Clinical Setting
Status: Enrolling
Updated: 7/23/2015
Click here to add this to my saved trials
Evaluation of Accuracy and Ease of Use of the FilmArray™ Respiratory Panel (RP EZ) in a CLIA-Waived Clinical Setting
Updated: 7/23/2015
Evaluation of Accuracy and Ease of Use of the FilmArray™ Respiratory Panel (RP EZ) in a CLIA-Waived Clinical Setting
Status: Enrolling
Updated: 7/23/2015
Evaluation of Accuracy and Ease of Use of the FilmArray™ Respiratory Panel (RP EZ) in a CLIA-Waived Clinical Setting
Updated: 7/23/2015
Evaluation of Accuracy and Ease of Use of the FilmArray™ Respiratory Panel (RP EZ) in a CLIA-Waived Clinical Setting
Status: Enrolling
Updated: 7/23/2015
Click here to add this to my saved trials
Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants
Updated: 7/28/2015
Efficacy of Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants
Status: Enrolling
Updated: 7/28/2015
Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants
Updated: 7/28/2015
Efficacy of Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants
Status: Enrolling
Updated: 7/28/2015
Click here to add this to my saved trials
Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants
Updated: 7/28/2015
Efficacy of Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants
Status: Enrolling
Updated: 7/28/2015
Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants
Updated: 7/28/2015
Efficacy of Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants
Status: Enrolling
Updated: 7/28/2015
Click here to add this to my saved trials
Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)
Updated: 7/28/2015
Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)
Status: Enrolling
Updated: 7/28/2015
Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)
Updated: 7/28/2015
Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)
Status: Enrolling
Updated: 7/28/2015
Click here to add this to my saved trials
Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)
Updated: 7/28/2015
Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)
Status: Enrolling
Updated: 7/28/2015
Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)
Updated: 7/28/2015
Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)
Status: Enrolling
Updated: 7/28/2015
Click here to add this to my saved trials
Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)
Updated: 7/28/2015
Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)
Status: Enrolling
Updated: 7/28/2015
Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)
Updated: 7/28/2015
Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)
Status: Enrolling
Updated: 7/28/2015
Click here to add this to my saved trials
Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)
Updated: 7/28/2015
Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)
Status: Enrolling
Updated: 7/28/2015
Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)
Updated: 7/28/2015
Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)
Status: Enrolling
Updated: 7/28/2015
Click here to add this to my saved trials
Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)
Updated: 7/28/2015
Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)
Status: Enrolling
Updated: 7/28/2015
Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)
Updated: 7/28/2015
Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)
Status: Enrolling
Updated: 7/28/2015
Click here to add this to my saved trials
Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)
Updated: 7/28/2015
Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)
Status: Enrolling
Updated: 7/28/2015
Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)
Updated: 7/28/2015
Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)
Status: Enrolling
Updated: 7/28/2015
Click here to add this to my saved trials
Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)
Updated: 7/28/2015
Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)
Status: Enrolling
Updated: 7/28/2015
Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)
Updated: 7/28/2015
Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)
Status: Enrolling
Updated: 7/28/2015
Click here to add this to my saved trials
Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)
Updated: 7/28/2015
Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)
Status: Enrolling
Updated: 7/28/2015
Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)
Updated: 7/28/2015
Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)
Status: Enrolling
Updated: 7/28/2015
Click here to add this to my saved trials
Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT
Updated: 7/30/2015
TBTC Study 33. An Evaluation of Adherence to Latent Tuberculosis Infection (LTBI) Treatment With 12 Doses of Once Weekly Rifapentine (RPT) and Isoniazid (INH) Given as Self-administered (SAT) Versus Directly-observed Therapy (DOT): iAdhere.
Status: Enrolling
Updated: 7/30/2015
Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT
Updated: 7/30/2015
TBTC Study 33. An Evaluation of Adherence to Latent Tuberculosis Infection (LTBI) Treatment With 12 Doses of Once Weekly Rifapentine (RPT) and Isoniazid (INH) Given as Self-administered (SAT) Versus Directly-observed Therapy (DOT): iAdhere.
Status: Enrolling
Updated: 7/30/2015
Click here to add this to my saved trials
Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT
Updated: 7/30/2015
TBTC Study 33. An Evaluation of Adherence to Latent Tuberculosis Infection (LTBI) Treatment With 12 Doses of Once Weekly Rifapentine (RPT) and Isoniazid (INH) Given as Self-administered (SAT) Versus Directly-observed Therapy (DOT): iAdhere.
Status: Enrolling
Updated: 7/30/2015
Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT
Updated: 7/30/2015
TBTC Study 33. An Evaluation of Adherence to Latent Tuberculosis Infection (LTBI) Treatment With 12 Doses of Once Weekly Rifapentine (RPT) and Isoniazid (INH) Given as Self-administered (SAT) Versus Directly-observed Therapy (DOT): iAdhere.
Status: Enrolling
Updated: 7/30/2015
Click here to add this to my saved trials
Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT
Updated: 7/30/2015
TBTC Study 33. An Evaluation of Adherence to Latent Tuberculosis Infection (LTBI) Treatment With 12 Doses of Once Weekly Rifapentine (RPT) and Isoniazid (INH) Given as Self-administered (SAT) Versus Directly-observed Therapy (DOT): iAdhere.
Status: Enrolling
Updated: 7/30/2015
Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT
Updated: 7/30/2015
TBTC Study 33. An Evaluation of Adherence to Latent Tuberculosis Infection (LTBI) Treatment With 12 Doses of Once Weekly Rifapentine (RPT) and Isoniazid (INH) Given as Self-administered (SAT) Versus Directly-observed Therapy (DOT): iAdhere.
Status: Enrolling
Updated: 7/30/2015
Click here to add this to my saved trials
Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT
Updated: 7/30/2015
TBTC Study 33. An Evaluation of Adherence to Latent Tuberculosis Infection (LTBI) Treatment With 12 Doses of Once Weekly Rifapentine (RPT) and Isoniazid (INH) Given as Self-administered (SAT) Versus Directly-observed Therapy (DOT): iAdhere.
Status: Enrolling
Updated: 7/30/2015
Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT
Updated: 7/30/2015
TBTC Study 33. An Evaluation of Adherence to Latent Tuberculosis Infection (LTBI) Treatment With 12 Doses of Once Weekly Rifapentine (RPT) and Isoniazid (INH) Given as Self-administered (SAT) Versus Directly-observed Therapy (DOT): iAdhere.
Status: Enrolling
Updated: 7/30/2015
Click here to add this to my saved trials
Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT
Updated: 7/30/2015
TBTC Study 33. An Evaluation of Adherence to Latent Tuberculosis Infection (LTBI) Treatment With 12 Doses of Once Weekly Rifapentine (RPT) and Isoniazid (INH) Given as Self-administered (SAT) Versus Directly-observed Therapy (DOT): iAdhere.
Status: Enrolling
Updated: 7/30/2015
Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT
Updated: 7/30/2015
TBTC Study 33. An Evaluation of Adherence to Latent Tuberculosis Infection (LTBI) Treatment With 12 Doses of Once Weekly Rifapentine (RPT) and Isoniazid (INH) Given as Self-administered (SAT) Versus Directly-observed Therapy (DOT): iAdhere.
Status: Enrolling
Updated: 7/30/2015
Click here to add this to my saved trials
Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT
Updated: 7/30/2015
TBTC Study 33. An Evaluation of Adherence to Latent Tuberculosis Infection (LTBI) Treatment With 12 Doses of Once Weekly Rifapentine (RPT) and Isoniazid (INH) Given as Self-administered (SAT) Versus Directly-observed Therapy (DOT): iAdhere.
Status: Enrolling
Updated: 7/30/2015
Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT
Updated: 7/30/2015
TBTC Study 33. An Evaluation of Adherence to Latent Tuberculosis Infection (LTBI) Treatment With 12 Doses of Once Weekly Rifapentine (RPT) and Isoniazid (INH) Given as Self-administered (SAT) Versus Directly-observed Therapy (DOT): iAdhere.
Status: Enrolling
Updated: 7/30/2015
Click here to add this to my saved trials
Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT
Updated: 7/30/2015
TBTC Study 33. An Evaluation of Adherence to Latent Tuberculosis Infection (LTBI) Treatment With 12 Doses of Once Weekly Rifapentine (RPT) and Isoniazid (INH) Given as Self-administered (SAT) Versus Directly-observed Therapy (DOT): iAdhere.
Status: Enrolling
Updated: 7/30/2015
Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT
Updated: 7/30/2015
TBTC Study 33. An Evaluation of Adherence to Latent Tuberculosis Infection (LTBI) Treatment With 12 Doses of Once Weekly Rifapentine (RPT) and Isoniazid (INH) Given as Self-administered (SAT) Versus Directly-observed Therapy (DOT): iAdhere.
Status: Enrolling
Updated: 7/30/2015
Click here to add this to my saved trials
Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT
Updated: 7/30/2015
TBTC Study 33. An Evaluation of Adherence to Latent Tuberculosis Infection (LTBI) Treatment With 12 Doses of Once Weekly Rifapentine (RPT) and Isoniazid (INH) Given as Self-administered (SAT) Versus Directly-observed Therapy (DOT): iAdhere.
Status: Enrolling
Updated: 7/30/2015
Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT
Updated: 7/30/2015
TBTC Study 33. An Evaluation of Adherence to Latent Tuberculosis Infection (LTBI) Treatment With 12 Doses of Once Weekly Rifapentine (RPT) and Isoniazid (INH) Given as Self-administered (SAT) Versus Directly-observed Therapy (DOT): iAdhere.
Status: Enrolling
Updated: 7/30/2015
Click here to add this to my saved trials
Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT
Updated: 7/30/2015
TBTC Study 33. An Evaluation of Adherence to Latent Tuberculosis Infection (LTBI) Treatment With 12 Doses of Once Weekly Rifapentine (RPT) and Isoniazid (INH) Given as Self-administered (SAT) Versus Directly-observed Therapy (DOT): iAdhere.
Status: Enrolling
Updated: 7/30/2015
Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT
Updated: 7/30/2015
TBTC Study 33. An Evaluation of Adherence to Latent Tuberculosis Infection (LTBI) Treatment With 12 Doses of Once Weekly Rifapentine (RPT) and Isoniazid (INH) Given as Self-administered (SAT) Versus Directly-observed Therapy (DOT): iAdhere.
Status: Enrolling
Updated: 7/30/2015
Click here to add this to my saved trials
Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT
Updated: 7/30/2015
TBTC Study 33. An Evaluation of Adherence to Latent Tuberculosis Infection (LTBI) Treatment With 12 Doses of Once Weekly Rifapentine (RPT) and Isoniazid (INH) Given as Self-administered (SAT) Versus Directly-observed Therapy (DOT): iAdhere.
Status: Enrolling
Updated: 7/30/2015
Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT
Updated: 7/30/2015
TBTC Study 33. An Evaluation of Adherence to Latent Tuberculosis Infection (LTBI) Treatment With 12 Doses of Once Weekly Rifapentine (RPT) and Isoniazid (INH) Given as Self-administered (SAT) Versus Directly-observed Therapy (DOT): iAdhere.
Status: Enrolling
Updated: 7/30/2015
Click here to add this to my saved trials
Efficacy of Micro-Patterned Foley Catheter to Reduce Catheter-Associated Urinary Tract Infection
Updated: 7/30/2015
Clinical Study to Assess the Efficacy of a Novel Micro-Patterned Foley Catheter to Reduce Catheter-Associated UrinaryTract Infection Among Spinal Cord Injury Patients
Status: Enrolling
Updated: 7/30/2015
Efficacy of Micro-Patterned Foley Catheter to Reduce Catheter-Associated Urinary Tract Infection
Updated: 7/30/2015
Clinical Study to Assess the Efficacy of a Novel Micro-Patterned Foley Catheter to Reduce Catheter-Associated UrinaryTract Infection Among Spinal Cord Injury Patients
Status: Enrolling
Updated: 7/30/2015
Click here to add this to my saved trials
Efficacy of Micro-Patterned Foley Catheter to Reduce Catheter-Associated Urinary Tract Infection
Updated: 7/30/2015
Clinical Study to Assess the Efficacy of a Novel Micro-Patterned Foley Catheter to Reduce Catheter-Associated UrinaryTract Infection Among Spinal Cord Injury Patients
Status: Enrolling
Updated: 7/30/2015
Efficacy of Micro-Patterned Foley Catheter to Reduce Catheter-Associated Urinary Tract Infection
Updated: 7/30/2015
Clinical Study to Assess the Efficacy of a Novel Micro-Patterned Foley Catheter to Reduce Catheter-Associated UrinaryTract Infection Among Spinal Cord Injury Patients
Status: Enrolling
Updated: 7/30/2015
Click here to add this to my saved trials
Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections
Updated: 8/4/2015
A Phase 2, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy, Safety, and PK of 2 Dose Regimens of TP-434 Compared With Ertapenem in Adult Community-Acquired Complicated Intra-abdominal Infections
Status: Enrolling
Updated: 8/4/2015
Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections
Updated: 8/4/2015
A Phase 2, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy, Safety, and PK of 2 Dose Regimens of TP-434 Compared With Ertapenem in Adult Community-Acquired Complicated Intra-abdominal Infections
Status: Enrolling
Updated: 8/4/2015
Click here to add this to my saved trials
Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections
Updated: 8/4/2015
A Phase 2, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy, Safety, and PK of 2 Dose Regimens of TP-434 Compared With Ertapenem in Adult Community-Acquired Complicated Intra-abdominal Infections
Status: Enrolling
Updated: 8/4/2015
Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections
Updated: 8/4/2015
A Phase 2, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy, Safety, and PK of 2 Dose Regimens of TP-434 Compared With Ertapenem in Adult Community-Acquired Complicated Intra-abdominal Infections
Status: Enrolling
Updated: 8/4/2015
Click here to add this to my saved trials
Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections
Updated: 8/4/2015
A Phase 2, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy, Safety, and PK of 2 Dose Regimens of TP-434 Compared With Ertapenem in Adult Community-Acquired Complicated Intra-abdominal Infections
Status: Enrolling
Updated: 8/4/2015
Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections
Updated: 8/4/2015
A Phase 2, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy, Safety, and PK of 2 Dose Regimens of TP-434 Compared With Ertapenem in Adult Community-Acquired Complicated Intra-abdominal Infections
Status: Enrolling
Updated: 8/4/2015
Click here to add this to my saved trials
Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections
Updated: 8/4/2015
A Phase 2, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy, Safety, and PK of 2 Dose Regimens of TP-434 Compared With Ertapenem in Adult Community-Acquired Complicated Intra-abdominal Infections
Status: Enrolling
Updated: 8/4/2015
Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections
Updated: 8/4/2015
A Phase 2, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy, Safety, and PK of 2 Dose Regimens of TP-434 Compared With Ertapenem in Adult Community-Acquired Complicated Intra-abdominal Infections
Status: Enrolling
Updated: 8/4/2015
Click here to add this to my saved trials
Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections
Updated: 8/4/2015
A Phase 2, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy, Safety, and PK of 2 Dose Regimens of TP-434 Compared With Ertapenem in Adult Community-Acquired Complicated Intra-abdominal Infections
Status: Enrolling
Updated: 8/4/2015
Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections
Updated: 8/4/2015
A Phase 2, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy, Safety, and PK of 2 Dose Regimens of TP-434 Compared With Ertapenem in Adult Community-Acquired Complicated Intra-abdominal Infections
Status: Enrolling
Updated: 8/4/2015
Click here to add this to my saved trials
Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections
Updated: 8/4/2015
A Phase 2, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy, Safety, and PK of 2 Dose Regimens of TP-434 Compared With Ertapenem in Adult Community-Acquired Complicated Intra-abdominal Infections
Status: Enrolling
Updated: 8/4/2015
Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections
Updated: 8/4/2015
A Phase 2, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy, Safety, and PK of 2 Dose Regimens of TP-434 Compared With Ertapenem in Adult Community-Acquired Complicated Intra-abdominal Infections
Status: Enrolling
Updated: 8/4/2015
Click here to add this to my saved trials
Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies
Updated: 8/4/2015
A Phase II Study to Evaluate the Efficacy of Posttransplant Cyclophosphamide for Prevention of Chronic Graft-versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation
Status: Enrolling
Updated: 8/4/2015
Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies
Updated: 8/4/2015
A Phase II Study to Evaluate the Efficacy of Posttransplant Cyclophosphamide for Prevention of Chronic Graft-versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation
Status: Enrolling
Updated: 8/4/2015
Click here to add this to my saved trials
Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study for Intravenous (IV) TKM-100802
Updated: 8/4/2015
A Placebo-Controlled, Single-Blind, Single-Ascending Dose Study With An Additional Multiple-Dose Cohort to Evaluate the Safety, Tolerability, and Pharmacokinetics of TKM-100802 in Healthy Human Volunteers
Status: Enrolling
Updated: 8/4/2015
Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study for Intravenous (IV) TKM-100802
Updated: 8/4/2015
A Placebo-Controlled, Single-Blind, Single-Ascending Dose Study With An Additional Multiple-Dose Cohort to Evaluate the Safety, Tolerability, and Pharmacokinetics of TKM-100802 in Healthy Human Volunteers
Status: Enrolling
Updated: 8/4/2015
Click here to add this to my saved trials
Effect of Copper Impregnated Textiles on Healthcare Associated Infections and Antibiotic Use
Updated: 8/4/2015
Effect of Copper Impregnated Textiles on Healthcare Associated Infections and Antibiotic Use in a Single Intensive Care Unit
Status: Enrolling
Updated: 8/4/2015
Effect of Copper Impregnated Textiles on Healthcare Associated Infections and Antibiotic Use
Updated: 8/4/2015
Effect of Copper Impregnated Textiles on Healthcare Associated Infections and Antibiotic Use in a Single Intensive Care Unit
Status: Enrolling
Updated: 8/4/2015
Click here to add this to my saved trials
Safety Surveillance of MenACWY-CRM Vaccine in Children
Updated: 8/5/2015
Post-licensure Observational Safety Surveillance Study of Quadrivalent Meningococcal ACWY Conjugate Vaccine MenACWY-CRM (Menveo) Vaccination in Children 2 Through 10 Years of Age
Status: Enrolling
Updated: 8/5/2015
Safety Surveillance of MenACWY-CRM Vaccine in Children
Updated: 8/5/2015
Post-licensure Observational Safety Surveillance Study of Quadrivalent Meningococcal ACWY Conjugate Vaccine MenACWY-CRM (Menveo) Vaccination in Children 2 Through 10 Years of Age
Status: Enrolling
Updated: 8/5/2015
Click here to add this to my saved trials
A Phase I/II Double-Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of RUT058-60
Updated: 8/5/2015
A Phase I/II Double-Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of RUT058-60 Lavage Following Abdominal Surgery as an Adjunctive Therapy to Prophylactic Systemic Antibiotics
Status: Enrolling
Updated: 8/5/2015
A Phase I/II Double-Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of RUT058-60
Updated: 8/5/2015
A Phase I/II Double-Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of RUT058-60 Lavage Following Abdominal Surgery as an Adjunctive Therapy to Prophylactic Systemic Antibiotics
Status: Enrolling
Updated: 8/5/2015
Click here to add this to my saved trials
A Phase I/II Double-Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of RUT058-60
Updated: 8/5/2015
A Phase I/II Double-Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of RUT058-60 Lavage Following Abdominal Surgery as an Adjunctive Therapy to Prophylactic Systemic Antibiotics
Status: Enrolling
Updated: 8/5/2015
A Phase I/II Double-Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of RUT058-60
Updated: 8/5/2015
A Phase I/II Double-Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of RUT058-60 Lavage Following Abdominal Surgery as an Adjunctive Therapy to Prophylactic Systemic Antibiotics
Status: Enrolling
Updated: 8/5/2015
Click here to add this to my saved trials
A Phase I/II Double-Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of RUT058-60
Updated: 8/5/2015
A Phase I/II Double-Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of RUT058-60 Lavage Following Abdominal Surgery as an Adjunctive Therapy to Prophylactic Systemic Antibiotics
Status: Enrolling
Updated: 8/5/2015
A Phase I/II Double-Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of RUT058-60
Updated: 8/5/2015
A Phase I/II Double-Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of RUT058-60 Lavage Following Abdominal Surgery as an Adjunctive Therapy to Prophylactic Systemic Antibiotics
Status: Enrolling
Updated: 8/5/2015
Click here to add this to my saved trials
A Phase I/II Double-Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of RUT058-60
Updated: 8/5/2015
A Phase I/II Double-Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of RUT058-60 Lavage Following Abdominal Surgery as an Adjunctive Therapy to Prophylactic Systemic Antibiotics
Status: Enrolling
Updated: 8/5/2015
A Phase I/II Double-Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of RUT058-60
Updated: 8/5/2015
A Phase I/II Double-Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of RUT058-60 Lavage Following Abdominal Surgery as an Adjunctive Therapy to Prophylactic Systemic Antibiotics
Status: Enrolling
Updated: 8/5/2015
Click here to add this to my saved trials
Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101)
Updated: 8/5/2015
A Randomized Double-blind Trial of Fluconazole Versus Voriconazole for the Prevention of Invasive Fungal Infections in Allogeneic Blood and Marrow Transplant Patients (BMT CTN #0101)
Status: Enrolling
Updated: 8/5/2015
Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101)
Updated: 8/5/2015
A Randomized Double-blind Trial of Fluconazole Versus Voriconazole for the Prevention of Invasive Fungal Infections in Allogeneic Blood and Marrow Transplant Patients (BMT CTN #0101)
Status: Enrolling
Updated: 8/5/2015
Click here to add this to my saved trials
Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101)
Updated: 8/5/2015
A Randomized Double-blind Trial of Fluconazole Versus Voriconazole for the Prevention of Invasive Fungal Infections in Allogeneic Blood and Marrow Transplant Patients (BMT CTN #0101)
Status: Enrolling
Updated: 8/5/2015
Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101)
Updated: 8/5/2015
A Randomized Double-blind Trial of Fluconazole Versus Voriconazole for the Prevention of Invasive Fungal Infections in Allogeneic Blood and Marrow Transplant Patients (BMT CTN #0101)
Status: Enrolling
Updated: 8/5/2015
Click here to add this to my saved trials
Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101)
Updated: 8/5/2015
A Randomized Double-blind Trial of Fluconazole Versus Voriconazole for the Prevention of Invasive Fungal Infections in Allogeneic Blood and Marrow Transplant Patients (BMT CTN #0101)
Status: Enrolling
Updated: 8/5/2015
Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101)
Updated: 8/5/2015
A Randomized Double-blind Trial of Fluconazole Versus Voriconazole for the Prevention of Invasive Fungal Infections in Allogeneic Blood and Marrow Transplant Patients (BMT CTN #0101)
Status: Enrolling
Updated: 8/5/2015
Click here to add this to my saved trials
Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101)
Updated: 8/5/2015
A Randomized Double-blind Trial of Fluconazole Versus Voriconazole for the Prevention of Invasive Fungal Infections in Allogeneic Blood and Marrow Transplant Patients (BMT CTN #0101)
Status: Enrolling
Updated: 8/5/2015
Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101)
Updated: 8/5/2015
A Randomized Double-blind Trial of Fluconazole Versus Voriconazole for the Prevention of Invasive Fungal Infections in Allogeneic Blood and Marrow Transplant Patients (BMT CTN #0101)
Status: Enrolling
Updated: 8/5/2015
Click here to add this to my saved trials